Fintech,raised properly
Payments, lending, wealth infrastructure and embedded finance, raised with materials that survive a diligence team who already knows the sector.
What is different about raising in fintech
Investors in fintech read unit economics before they read the vision. Contribution margin per account, CAC payback and cohort retention decide the meeting.
Your own regulatory position (authorised, appointed representative, or relying on a partner licence) is a diligence line item rather than an appendix.
Most fintech rounds are lost in the data room, not the pitch: missing cohort data, no reconciliation of reported revenue to processor statements.
The engine behind the raise
Capital types we most often work across here: Venture capital, Growth equity, Private credit.
- Investment memorandum and deck built around unit economics, cohorts and the licence position
- Financial model review: take rate, contribution margin, CAC payback, runway sensitivity
- Data room indexed for fintech diligence, including regulatory permissions and key contracts
- Investor audience built from people who actually deploy into fintech, not a bought list
- Financial promotion perimeter check on every investor-facing asset before it goes out
The questions capital will ask
If you cannot answer these with evidence in the data room, the process stalls at week two.
- What is your monthly recurring revenue and net revenue retention?
- What is your regulatory permission or partner arrangement, and is it in your name?
- What is CAC payback by cohort, and how has it moved in the last four quarters?
- Who is on the cap table, and is there an institutional lead already committed?
We work across private markets
Deeptech
Hard science, long horizons and technical risk, presented so a generalist committee can underwrite what a specialist already understands.
View sectorTechnology and software
SaaS, marketplaces and platforms, raised on metrics that reconcile to the accounts rather than to a slide.
View sectorLife sciences
Clinical, regulatory and reimbursement risk explained in one sequence a committee can underwrite.
View sectorBiotech
Platform or asset, preclinical or clinical, the raise gets built around what the next milestone proves and what it costs.
View sectorHealthtech
Digital health and care technology, raised on adoption evidence, procurement reality and a credible route to contracted revenue.
View sectorEngineering and industrials
Manufacturing, advanced engineering and industrial businesses, raised on order book, capacity and the capex plan behind them.
View sectorCleantech and energy transition
Where technology risk meets project risk, raised with the structure, offtake and permitting position resolved before outreach begins.
View sectorInfrastructure projects
Shovel-ready or nearly there, raised on planning, permits, offtake and a contracting structure that stands up to lender diligence.
View sectorReal estate
Development and income strategies, raised on site control, planning status, debt position and a stated exit.
View sectorPrivate credit
Borrowers and sponsors raising private debt, presented with the security package, coverage and covenant position resolved up front.
View sectorSustainable Wealth Group is not authorised or regulated by the Financial Conduct Authority. Nothing on this page is advice, or an invitation or inducement to engage in investment activity. Capital at risk.